In the BioHarmony Drug Report Database

"Preview" Icon

Selinexor

Xpovio, Nexpovio (selinexor) is a small molecule pharmaceutical. Selinexor was first approved as Xpovio on 2019-07-03. It is used to treat multiple myeloma in the USA. It has been approved in Europe to treat multiple myeloma. It is known to target exportin-1. Xpovio’s patents are valid until 2035-08-14 (FDA).

 

Trade Name

 

Nexpovio
 

Common Name

 

selinexor
 

ChEMBL ID

 

CHEMBL3545185
 

Indication

 

multiple myeloma
 

Drug Class

 

Exportin 1 inhibitors

Image (chem structure or protein)

Selinexor structure rendering